Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT03252587

Public ClinicalTrials.gov record NCT03252587. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 9:18 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BMS-986165 in Subjects With Systemic Lupus Erythematosus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will investigate BMS-986165 to assess its effects in participants with systemic lupus erythematosus (SLE).

Study identification

NCT ID
NCT03252587
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
363 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 21, 2017 (Actual)
Primary completion
Jun 29, 2021 (Actual)
Completion
Oct 28, 2021 (Actual)
Last update posted
Dec 20, 2022

2017 – 2021

United States locations

U.S. sites
55
U.S. states
19
U.S. cities
48
Facility City State ZIP Site status
Local Institution - 0178 Birmingham Alabama 35205 —
Little Rock Diagnostic Clinic Little Rock Arkansas 72205 —
Local Institution - 0023 El Cajon California 92020 —
BioSolutions Clinical Research Center La Mesa California 91942 —
Los Angeles County Hospital and University of Southern California Medical Center Los Angeles California 90033 —
University of California at Irvine College of Medicine Orange California 92868 —
Local Institution - 0227 Palm Desert California 92260 —
Millennium Clinical Trials - Thousand Oaks Thousand Oaks California 91360 —
The Lundquist Institute at Harbor-UCLA Medical Center Torrance California 90502 —
Inland Rheumatology Clinical Trials Upland California 91786 —
Local Institution - 0034 Farmington Connecticut 06030-5353 —
Local Institution - 0195 New Haven Connecticut 06520-8018 —
Local Institution - 0010 Aventura Florida 33180 —
Local Institution - 0066 Brandon Florida 33511 —
Local Institution - 0214 Gainesville Florida 32603 —
Local Institution - 0233 Orlando Florida 32808 —
Local Institution - 0057 Ormond Beach Florida 32174-1139 —
Local Institution - 0002 Tamarac Florida 33321 —
Local Institution - 0038 Tampa Florida 33613 —
BayCare Medical Group Tampa Florida 33614 —
Local Institution - 0206 Atlanta Georgia 30303 —
Local Institution - 0022 Decatur Georgia 30033 —
Local Institution - 0083 Lawrenceville Georgia 30046 —
Arthritis Research and Treatment Center Stockbridge Georgia 30281 —
Klein & Associates Cumberland Maryland 21502 —
Klein and Associates Hagerstown Maryland 21740 —
Advanced Rheumatology - Lansing Lansing Michigan 48910 —
University of Minnesota Minneapolis Minnesota 55455-0341 —
University of Mississippi Medical Center Jackson Mississippi 39216 —
Local Institution - 0011 Brooklyn New York 11201 —
SUNY Downstate Health Science University Brooklyn New York 11203 —
Local Institution - 0082 Lake Success New York 11042 —
Local Institution - 0109 New York New York 10016 —
Local Institution - 0232 New York New York 10032 —
Local Institution - 0119 Chapel Hill North Carolina 27599-7280 —
Local Institution - 0026 Charlotte North Carolina 28204 —
Local Institution - 0180 Oklahoma City Oklahoma 73103 —
Local Institution - 0197 Oklahoma City Oklahoma 73104 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15261 —
Local Institution - 0174 Wyomissing Pennsylvania 19610 —
Local Institution - 0190 Charleston South Carolina 29425 —
Local Institution - 0001 Jackson Tennessee 38305 —
University of Tennessee Health Science Center Memphis Tennessee 38163 —
Local Institution - 0087 Austin Texas 78731-3146 —
Local Institution - 0086 Austin Texas 78745 —
Pioneer Research Solutions Cypress Texas 77429-5890 —
Baylor Research Institute Dallas Texas 75231 —
Local Institution - 0193 Dallas Texas 75390 —
Local Institution - 0204 Houston Texas 77084 —
Local Institution - 0061 Houston Texas 77089 —
Local Institution - 0047 Mesquite Texas 75150 —
Arthritis and Osteoporosis Center of South Texas San Antonio Texas 78232 —
Local Institution - 0171 Chesapeake Virginia 23320-4985 —
University of Washington Seattle Washington 98195 —
Arthritis Northwest, PLLC Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 137 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03252587, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 20, 2022 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03252587 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →